Edgar Meinl
Großhaderner Str. 9
Planegg, BY 82152, Germany
Planegg, BY 82152, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 94 publications
Antibodies against MLC1 found in patients with NMOSD-like disease mediate astrocytopathy in rodent models.
Journal: Science translational medicine
Published: August 26, 2026
Triggering multiple sclerosis: infection with Epstein-Barr virus activates multiple pre-existing autoreactive B and T cells.
Journal: Signal transduction and targeted therapy
Published: February 04, 2026
Synaptophysin autoantibodies mediate synaptic dysfunction in cerebellar ataxia.
Journal: Cell reports. Medicine
Published: August 27, 2025
CD20+ natural killer cells are polyfunctional, memory-like cells that are enriched in inflammatory disorders.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: January 10, 2025
Ravulizumab and other complement inhibitors for the treatment of autoimmune disorders.
Journal: Multiple sclerosis and related disorders
Published: October 24, 2024
B-Cell Maturation Antigen (BCMA) as a Biomarker and Potential Treatment Target in Systemic Lupus Erythematosus.
Journal: International journal of molecular sciences
Published: August 30, 2024
BTK-Inhibition Enhances TLR-7-Mediated Interferon-Alpha Production in pDCs by Blocking the Inhibitory BDCA-2 Pathway.
Journal: European journal of immunology
Published: January 04, 2024
Intramuscular vaccination against SARS-CoV-2 transiently induces neutralizing IgG rather than IgA in the saliva.
Journal: Frontiers in immunology
Published: October 31, 2023
Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response.
Journal: Therapeutic advances in neurological disorders
Published: June 14, 2023
MOG-IgG-Associated Bilateral Optic Neuritis in Temporal Relation to Monkeypox Vaccination.
Journal: Annals of neurology
Published: April 14, 2023
Dissection of complement and Fc-receptor-mediated pathomechanisms of autoantibodies to myelin oligodendrocyte glycoprotein.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 21, 2023
Ublituximab: A new FDA-approved anti-CD20 mAb for relapsing forms of multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: March 02, 2023
Last Updated: 09/26/2026